NCT03931668View on ClinicalTrials.gov

Tolerance, PK and PD Effects Study of TPN-672 in Chinese Healthy Volunteers

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

October 17, 2020

Study Completion Date

December 17, 2020

Conditions
PHA1A
Interventions
DRUG

TPN-672

single dose of TPN-672 maleate tablet

Trial Locations (1)

200030

RECRUITING

Shanghai Mental Health Center, Shanghai

Sponsors
All Listed Sponsors
collaborator

Jiangsu Kanion Pharmaceutical Co.

OTHER

lead

Shanghai Mental Health Center

OTHER

NCT03931668 - Tolerance, PK and PD Effects Study of TPN-672 in Chinese Healthy Volunteers | Biotech Hunter | Biotech Hunter